231 related articles for article (PubMed ID: 34367174)
21. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
[TBL] [Abstract][Full Text] [Related]
22. ADAM17-mediated shedding of FcγRIIIA on human NK cells: identification of the cleavage site and relationship with activation.
Lajoie L; Congy-Jolivet N; Bolzec A; Gouilleux-Gruart V; Sicard E; Sung HC; Peiretti F; Moreau T; Vié H; Clémenceau B; Thibault G
J Immunol; 2014 Jan; 192(2):741-51. PubMed ID: 24337742
[TBL] [Abstract][Full Text] [Related]
23. Upregulation of Natural Killer Cells Proliferation by Cytokine Stimulation.
Pencheva-Demireva M; El-Darawish Y; Kavaldzhieva K; Mladenov N; Lazarov V; Dimitrova-Dikanarova D; Markova T; Nikolov R; Okamura H
Monoclon Antib Immunodiagn Immunother; 2019 Apr; 38(2):85-88. PubMed ID: 31009333
[TBL] [Abstract][Full Text] [Related]
24. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
25. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo.
Huntington ND; Legrand N; Alves NL; Jaron B; Weijer K; Plet A; Corcuff E; Mortier E; Jacques Y; Spits H; Di Santo JP
J Exp Med; 2009 Jan; 206(1):25-34. PubMed ID: 19103877
[TBL] [Abstract][Full Text] [Related]
26. Autonomous growth and increased cytotoxicity of natural killer cells expressing membrane-bound interleukin-15.
Imamura M; Shook D; Kamiya T; Shimasaki N; Chai SM; Coustan-Smith E; Imai C; Campana D
Blood; 2014 Aug; 124(7):1081-8. PubMed ID: 25006133
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human prolactin improves antitumor effects of murine natural killer cells in vitro and in vivo.
Sun R; Wei H; Zhang J; Li A; Zhang W; Tian Z
Neuroimmunomodulation; 2002-2003; 10(3):169-76. PubMed ID: 12481157
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic applications: natural killer cells in the clinic.
Miller JS
Hematology Am Soc Hematol Educ Program; 2013; 2013():247-53. PubMed ID: 24319187
[TBL] [Abstract][Full Text] [Related]
29. In Vivo Activation of Human NK Cells by Treatment with an Interleukin-15 Superagonist Potently Inhibits Acute In Vivo HIV-1 Infection in Humanized Mice.
Seay K; Church C; Zheng JH; Deneroff K; Ochsenbauer C; Kappes JC; Liu B; Jeng EK; Wong HC; Goldstein H
J Virol; 2015 Jun; 89(12):6264-74. PubMed ID: 25833053
[TBL] [Abstract][Full Text] [Related]
30. miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.
Yu CC; Tsai LL; Wang ML; Yu CH; Lo WL; Chang YC; Chiou GY; Chou MY; Chiou SH
Cancer Res; 2013 Jun; 73(11):3425-40. PubMed ID: 23548270
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells.
Chiossone L; Vitale C; Cottalasso F; Moretti S; Azzarone B; Moretta L; Mingari MC
Blood; 2007 May; 109(9):3767-75. PubMed ID: 17234744
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-21 induces proliferation and modulates receptor expression and effector function in canine natural killer cells.
Shin DJ; Lee SH; Park JY; Kim JS; Lee JJ; Suh GH; Lee YK; Cho D; Kim SK
Vet Immunol Immunopathol; 2015 May; 165(1-2):22-33. PubMed ID: 25819349
[TBL] [Abstract][Full Text] [Related]
33. NKG2D Signaling between Human NK Cells Enhances TACE-Mediated TNF-α Release.
Sharma N; Trinidad CV; Trembath AP; Markiewicz MA
J Immunol; 2017 Oct; 199(8):2865-2872. PubMed ID: 28893955
[TBL] [Abstract][Full Text] [Related]
34. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
[TBL] [Abstract][Full Text] [Related]
35. A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival.
Perez SA; Mahaira LG; Demirtzoglou FJ; Sotiropoulou PA; Ioannidis P; Iliopoulou EG; Gritzapis AD; Sotiriadou NN; Baxevanis CN; Papamichail M
Blood; 2005 Jul; 106(1):158-66. PubMed ID: 15755904
[TBL] [Abstract][Full Text] [Related]
36. CD62L expression identifies a unique subset of polyfunctional CD56dim NK cells.
Juelke K; Killig M; Luetke-Eversloh M; Parente E; Gruen J; Morandi B; Ferlazzo G; Thiel A; Schmitt-Knosalla I; Romagnani C
Blood; 2010 Aug; 116(8):1299-307. PubMed ID: 20505160
[TBL] [Abstract][Full Text] [Related]
37. ADAM17 activity and other mechanisms of soluble L-selectin production during death receptor-induced leukocyte apoptosis.
Wang Y; Zhang AC; Ni Z; Herrera A; Walcheck B
J Immunol; 2010 Apr; 184(8):4447-54. PubMed ID: 20220092
[TBL] [Abstract][Full Text] [Related]
38. A Genetically Engineered Primary Human Natural Killer Cell Platform for Cancer Immunotherapy.
Pomeroy EJ; Hunzeker JT; Kluesner MG; Lahr WS; Smeester BA; Crosby MR; Lonetree CL; Yamamoto K; Bendzick L; Miller JS; Geller MA; Walcheck B; Felices M; Webber BR; Starr TK; Moriarity BS
Mol Ther; 2020 Jan; 28(1):52-63. PubMed ID: 31704085
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
Biron CA; Young HA; Kasaian MT
J Exp Med; 1990 Jan; 171(1):173-88. PubMed ID: 1688606
[TBL] [Abstract][Full Text] [Related]
40. Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells.
Lee SH; Shin DJ; Kim SK
Vet Immunol Immunopathol; 2015 May; 165(1-2):1-13. PubMed ID: 25890849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
